Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marco Capobianco

Showing results (21-30 of 76) with videos related to

Pageof 8
Sort By:
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|October 4, 2008
Glatiramer acetate is a treatment option in neutralising antibodies to interferon-beta-positive patientsMarco Capobianco, Annalisa Rizzo, Simona Malucchi, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|September 28, 2018
Rituximab-induced hypogammaglobulinemia in patients with neuromyelitis optica spectrum disordersAndrea Marcinnò, Fabiana Marnetto, Paola Valentino, et al.
Open Medicine (Warsaw, Poland)|March 30, 2017
Anal sphincter dysfunction in multiple sclerosis: an observation manometric studySilvia Marola, Alessia Ferrarese, Enrico Gibin, et al.
Molecular Diagnosis : a Journal Devoted to the Understanding of Human Disease Through the Clinical Application of Molecular Biology|March 18, 2005
Comparison of three PCR assays for the evaluation of interferon-beta biological activity in patients with multiple sclerosisFrancesca Gilli, Fabiana Marnetto, Guglielmo Stefanuto, et al.
Neurology and Therapy|February 24, 2023
Understanding Treatment Decisions in Neuromyelitis Optica Spectrum Disorder: A Global Clinical Record Review with Patient InterviewsJu-Hong Min, Marco Capobianco, Carly Welsh, et al.
Plos One|June 22, 2012
Evaluation of a multiparametric immunofluorescence assay for standardization of neuromyelitis optica serologyLetizia Granieri, Fabiana Marnetto, Paola Valentino, et al.
Journal of Neuroimmunology|October 24, 2009
Western blot analysis for the detection of serum antibodies recognizing linear Aquaporin-4 epitopes in patients with Neuromyelitis OpticaFabiana Marnetto, Bianca Hellias, Letizia Granieri, et al.
Neurology and Therapy|February 24, 2023
Characterization of Disease Severity and Stability in NMOSD: A Global Clinical Record Review with Patient InterviewsMarco Capobianco, Marius Ringelstein, Carly Welsh, et al.
Brain : a Journal of Neurology|November 11, 2003
Neutralizing antibodies against IFN-beta in multiple sclerosis: antagonization of IFN-beta mediated suppression of MMPsFrancesca Gilli, Antonio Bertolotto, Arianna Sala, et al.
Journal of Neurology|May 21, 2024
Moving towards a new era for the treatment of neuromyelitis optica spectrum disordersPaolo Preziosa, Maria Pia Amato, Luca Battistini, et al.
Pageof 8

Showing results (21-30 of 76) with videos related to

Sort By:
Pageof 8
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|October 4, 2008
Glatiramer acetate is a treatment option in neutralising antibodies to interferon-beta-positive patientsMarco Capobianco, Annalisa Rizzo, Simona Malucchi, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|September 28, 2018
Rituximab-induced hypogammaglobulinemia in patients with neuromyelitis optica spectrum disordersAndrea Marcinnò, Fabiana Marnetto, Paola Valentino, et al.
Open Medicine (Warsaw, Poland)|March 30, 2017
Anal sphincter dysfunction in multiple sclerosis: an observation manometric studySilvia Marola, Alessia Ferrarese, Enrico Gibin, et al.
Molecular Diagnosis : a Journal Devoted to the Understanding of Human Disease Through the Clinical Application of Molecular Biology|March 18, 2005
Comparison of three PCR assays for the evaluation of interferon-beta biological activity in patients with multiple sclerosisFrancesca Gilli, Fabiana Marnetto, Guglielmo Stefanuto, et al.
Neurology and Therapy|February 24, 2023
Understanding Treatment Decisions in Neuromyelitis Optica Spectrum Disorder: A Global Clinical Record Review with Patient InterviewsJu-Hong Min, Marco Capobianco, Carly Welsh, et al.
Plos One|June 22, 2012
Evaluation of a multiparametric immunofluorescence assay for standardization of neuromyelitis optica serologyLetizia Granieri, Fabiana Marnetto, Paola Valentino, et al.
Journal of Neuroimmunology|October 24, 2009
Western blot analysis for the detection of serum antibodies recognizing linear Aquaporin-4 epitopes in patients with Neuromyelitis OpticaFabiana Marnetto, Bianca Hellias, Letizia Granieri, et al.
Neurology and Therapy|February 24, 2023
Characterization of Disease Severity and Stability in NMOSD: A Global Clinical Record Review with Patient InterviewsMarco Capobianco, Marius Ringelstein, Carly Welsh, et al.
Brain : a Journal of Neurology|November 11, 2003
Neutralizing antibodies against IFN-beta in multiple sclerosis: antagonization of IFN-beta mediated suppression of MMPsFrancesca Gilli, Antonio Bertolotto, Arianna Sala, et al.
Journal of Neurology|May 21, 2024
Moving towards a new era for the treatment of neuromyelitis optica spectrum disordersPaolo Preziosa, Maria Pia Amato, Luca Battistini, et al.
Pageof 8